One Platform Complete Compliance Intelligence.
Oyasin AI brings together multimodal analysis, explainable AI, and regulatory intelligence to help pharmaceutical teams prepare stronger, faster, and more compliant promotional content before formal MLR review.
Starter
Perfect for biotech startups and small regulatory teams.- AI-assisted Pre-MLR Review
- Claim–Evidence Validation
- Text & Document Analysis
- Explainable AI Feedback
- Compliance Risk Detection
- Review Summary Report
- Image & Visual Analysis
- Custom Compliance Rules
- Veeva Integration
- Priority Support
Professional
Built for growing Medical, Legal, and Regulatory teams.- Everything in Starter
- Multimodal Content Review
- Image & Visual Analysis
- Chart & Table Validation
- Cross-Reference Verification
- Explainable AI Reports
- Review History & Audit Trail
- Priority Support
- Dedicated Customer Success Manager
- Custom AI Models
Enterprise
Designed for global pharmaceutical organizations.- Everything in Professional
- Custom AI Compliance Models
- Private & Secure Deployment
- Veeva & Workflow Integrations
- Global Compliance Frameworks
- Dedicated Customer Success Manager
- Custom Regulatory Rules
- Multi-country Compliance Support
- Enterprise Audit & Governance
- Custom Onboarding & Training
Multimodal Content Review
Review promotional content the way regulators do, not one element at a time, but as a complete communication.
Oyasin AI analyzes text, visuals, charts, tables, citations, and safety information together to identify risks that traditional document review often misses.
✓ Text, Images & Layout / Charts & Tables
Safety Information
Explainable Compliance Intelligence
AI should never be a black box.
Every recommendation includes a clear explanation of why content was flagged, what evidence is missing, and how to strengthen compliance before Medical, Legal, and Regulatory review.
✓ Transparent AI Decisions / Claim Validation
✓ Evidence Gap Detection / Suggested Improvements
Frequently Asked Questions
Everything you need to know before getting started with Oyasin AI.
What type of content can Oyasin AI review?
Oyasin AI is designed for pharmaceutical promotional and medical content, including slide decks, sales aids, websites, email campaigns, brochures, congress posters, social media materials, and other regulated assets. The platform reviews text, visuals, charts, tables, citations, safety information, and document layout together.
Does Oyasin AI replace Medical, Legal, and Regulatory (MLR) review?
No. Oyasin AI is built to support your Medical, Legal, and Regulatory teams. It identifies potential compliance risks before formal review, helping reviewers focus on higher-value decisions while reducing manual effort and review cycles.
Is our confidential content secure?
Yes. Security and confidentiality are core priorities. Customer documents are never used to train public AI models. Enterprise deployments can be configured within secure private environments to meet organizational security and compliance requirements.
Is Oyasin AI available today?
Oyasin AI is currently in active development. We are working closely with pharmaceutical companies and regulatory professionals to refine the platform through customer discovery and pilot collaborations. Contact us if you are interested in early access, product demonstrations, or pilot opportunities.